HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

OSU 03012

a PDK-1 inhibitor; structure in first source
Also Known As:
2-amino-N-(4-(5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)phenyl)acetamide; OSU-03012
Networked: 25 relevant articles (0 outcomes, 7 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Chen, Ching-Shih: 12 articles (12/2012 - 02/2006)
2. Dent, Paul: 7 articles (08/2015 - 08/2006)
3. Booth, Laurence: 5 articles (08/2015 - 02/2012)
4. Grant, Steven: 5 articles (10/2014 - 08/2006)
5. Kulp, Samuel K: 4 articles (06/2009 - 11/2007)
6. Roberts, Jane L: 3 articles (08/2015 - 10/2014)
7. Park, Margaret A: 3 articles (01/2013 - 08/2006)
8. Yacoub, Adly: 3 articles (02/2012 - 08/2006)
9. Wang, Yu-Chieh: 3 articles (04/2008 - 11/2006)
10. Poklepovic, Andrew: 2 articles (08/2015 - 10/2014)

Related Diseases

1. Glioblastoma (Glioblastoma Multiforme)
2. Neoplasms (Cancer)
3. Breast Neoplasms (Breast Cancer)
4. Prostatic Neoplasms (Prostate Cancer)
5. Melanoma (Melanoma, Malignant)

Related Drugs and Biologics

1. lapatinib (GW572016)
2. Estrogens (Estrogen)
3. sorafenib (BAY 43-9006)
4. Neurofibromin 2 (Merlin)
5. Interleukins
6. Glucose (Dextrose)
7. Dimethyl Sulfoxide (DMSO)
8. bevacizumab
9. picropodophyllin
10. erlotinib (CP 358,774)

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Radiotherapy